Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Phemex Announces Holiday Trading Campaign: Win a Luxury Bali Holiday!
-
Qualifacts Consolidates Tampa Operations into New, Modern Office Space and Celebrates with Grand Opening
-
AUDIENCEX Celebrates Landmark Year of Tech Innovation and Impact, Unveils Vision for 2025
-
IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer
-
Primech AI Partners with Leading Japanese Hotel Group to Launch HYTRON
-
Primech AI Partners with Leading Japanese Hotel Group to Launch HYTRON
-
ProStar Announces a Reduction in Operational Costs and Amends the Company’s Long-Term Incentive Plan
-
SONORO GOLD CLOSES C$500,000 PRIVATE PLACEMENT
-
NexGold Announces Grant of Restricted Share Units
-
Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis
-
Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
-
reAlpha Plans to Allocate up to 25% of Excess Cash to Cryptocurrency Purchases
-
Allegro MicroSystems to Showcase Its Dynamic Sensing and Power Solutions at CES 2025
-
Advent Technologies Proudly Supports the Wounded Warrior Project
-
RWA Inc Expands Ecosystem with L2 Blockchain and DEX Launch
-
March Biosciences Elects Peter Olagunju as Chair of Board of Directors
-
Condor Provides an Operational Update for Uzbekistan
-
Alumis Announces Positive Phase 1 Data for CNS Penetrant TYK2 Inhibitor, A-005
-
Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan
-
Big 5 Sporting Goods Corporation Announces Renewal of Five-Year Credit Facility
-
American Oncology Network’s Specialty Pharmacy Achieves ACHC Reaccreditation
-
Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic Retinopathy
-
Playa Bowls Chooses Qu to Support Rapid Growth and Streamline Operations Across Its Expanding Network of Locations
-
Highwire Appoints Mike Steavenson as Executive Vice President of Enterprise Technology Practice, Elevates Jason Mayde to CTO
-
NV5 Awarded $7 Million in Infrastructure Design Contracts by the City of Philadelphia
-
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
-
JumpCloud's G2 Scores Prove Its Leadership in Simplified IT Management
-
Driivz Concludes 2024 with Significant Growth for its EV Charging & Energy Management Platform
-
AgEagle Aerial Systems Announces Milestone Order of 60 RedEdge-P Multispectral Sensors
-
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
-
Liberty Star Announces Assay Results from The Hay Mountain Project Red Rock Canyon MEP Area Containing Bonanza Grade Gold Results
-
Ladybug Resource Group Accelerates Strategy and Expands E-Commerce Portfolio With Key Acquisitions
-
Duos Partners with Texas City for Data Center Development
-
Ultragenyx Submits Biologics License Application to the U.S. FDA for UX111 AAV Gene Therapy for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)
-
Sky Quarry Inc. Issues Annual Shareholder Letter and Corporate Update
-
Gold and Gemstone Mining Achieves Record $8.6 Million Revenue
-
Gaxos.ai Inc. Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
-
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
-
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal
-
Golden Matrix Group to Participate in the 2025 ICR Conference
-
Shareholder Update From the Desk of H. Wyatt Flippen, CEO and Board Member
-
authID Bolsters Security and Transparency for Philanthropy Efforts with Program Expansion at EinStrong Foundation
-
D. Boral Capital Acted as Exclusive Placement Agent to Webuy Global Ltd (Nasdaq: WBUY) in connection with its $3.7 Million Registered Direct Offering
-
Immuneering Launches Pancreatic Cancer Advisory Board
-
Applied Digital Sets Fiscal Second Quarter 2025 Conference Call for Tuesday, January 14, 2025, at 5:00 p.m. Eastern Time
-
illumin Announces TSX Acceptance of Normal Course Issuer Bid
-
Driivz Concludes 2024 with Significant Growth for its EV Charging & Energy Management Platform
